Journal article
Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.
- Abstract:
-
Interferon-alpha-2b (IFNalpha2b) is the only effective adjuvant therapy for melanoma patients at high risk of recurrence that has been approved by regulatory authorities worldwide. However, IFN toxicities increase the risk of poor treatment compliance and impair the potential for benefit from this agent. A review of the literature demonstrated little recent attention to supportive care in the management of IFN toxicities. An international group of experts with extensive personal experience in...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cancer
- Volume:
- 112
- Issue:
- 5
- Pages:
- 982-994
- Publication date:
- 2008-03-01
- DOI:
- EISSN:
-
1097-0142
- ISSN:
-
0008-543X
- Source identifiers:
-
120072
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:120072
- UUID:
-
uuid:6193af00-34c2-4460-8a83-8140f20ba33b
- Local pid:
- pubs:120072
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2008
If you are the owner of this record, you can report an update to it here: Report update to this record